Humana Stock Forecast, Price & News

Humana's stock was trading at $328.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HUM stock has increased by 26.3% and is now trading at $414.60.
View which stocks have been most impacted by COVID-19.

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 5 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Humana stock.
View analyst ratings for Humana or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Humana a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Humana wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

6,978 employees have rated Humana CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Humana's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Humana.

Humana will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Humana Inc. (NYSE:HUM) announced its quarterly earnings data on Tuesday, November, 3rd. The insurance provider reported $3.08 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.81 by $0.27. The insurance provider had revenue of $20.08 billion for the quarter, compared to analysts' expectations of $18.59 billion. Humana had a net margin of 5.58% and a return on equity of 22.74%. The business's quarterly revenue was up 23.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.03 EPS.
View Humana's earnings history.

Humana announced a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Thursday, December 31st will be given a dividend of $0.625 per share on Friday, January 29th. This represents a $2.50 annualized dividend and a yield of 0.60%. The ex-dividend date is Wednesday, December 30th.
View Humana's dividend history.

Humana pays an annual dividend of $2.50 per share and currently has a dividend yield of 0.61%. Humana has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Humana is 13.99%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Humana will have a dividend payout ratio of 11.50% next year. This indicates that Humana will be able to sustain or increase its dividend.
View Humana's dividend history.

Humana updated its fourth quarter earnings guidance on Tuesday, January, 5th. The company provided EPS guidance of ($2.40) for the period, compared to the Thomson Reuters consensus estimate of ($2.37).

20 brokerages have issued 12-month price targets for Humana's shares. Their forecasts range from $406.00 to $510.00. On average, they expect Humana's share price to reach $459.43 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for Humana or view Wall Street analyst' top-rated stocks.

Humana saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 1,460,000 shares, a drop of 17.5% from the December 15th total of 1,770,000 shares. Based on an average daily volume of 766,000 shares, the short-interest ratio is presently 1.9 days. Approximately 1.1% of the company's shares are short sold.
View Humana's Short Interest.

Some companies that are related to Humana include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Centene (CNC), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS).
View all of HUM's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), The Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), The Boeing (BA), salesforce.com (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Humana's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Ardevora Asset Management LLP (0.10%), Frontier Capital Management Co. LLC (0.07%), Wedge Capital Management L L P NC (0.05%), Rhenman & Partners Asset Management AB (0.04%), Baldwin Brothers Inc. MA (0.03%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Christopher H Hunter, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval.
View institutional ownership trends for Humana.

HUM stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Hexavest Inc., Pendal Group Limited, Pacer Advisors Inc., Baldwin Brothers Inc. MA, Rhenman & Partners Asset Management AB, Smith Graham & Co. Investment Advisors LP, and MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH. Company insiders that have sold Humana company stock in the last year include David A Jr/Ky Jones, and Timothy S Huval.
View insider buying and selling activity for Humana or view top insider-selling stocks.

HUM stock was bought by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Journey Advisory Group LLC, Kestra Advisory Services LLC, Manning & Napier Group LLC, Wedge Capital Management L L P NC, IFM Investors Pty Ltd, Louisiana State Employees Retirement System, and Oxinas Partners Wealth Management LLC.
View insider buying and selling activity for Humana or or view top insider-buying stocks.

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HUM stock can currently be purchased for approximately $414.60.

Humana has a market capitalization of $54.87 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe.

The official website for Humana is www.humana.com.

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]